Identification of a novel estrogen receptor β1 binding partner, inhibitor of differentiation-1, and role of ERβ1 in human breast cancer cells

Cancer Letters

Volumn 278, Issue 2, 2009, Pages 210-219

  Chen, Li ^a   Qiu, Juhui ^a   Yang, Cheng ^a   Yang, Xinghua ^a   Chen, Xianchun ^a   Jiang, Jun ^a   Luo, Xiangdong ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Breast cancer; Estrogen receptor 1; Inhibitor of differentiation 1

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1; ESTRADIOL; ESTROGEN RECEPTOR BETA; ESTROGEN RECEPTOR BETA1; HELIX LOOP HELIX PROTEIN; INHIBITOR OF DIFFERENTIATION 1; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CANCER CELL; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; UPREGULATION;

BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLIN-DEPENDENT KINASE INHIBITOR P21; ESTRADIOL; ESTROGEN RECEPTOR BETA; FEMALE; HUMANS; INHIBITOR OF DIFFERENTIATION PROTEIN 1;

MAMMALIA;

EID: 64649094812     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2009.01.008     Document Type: Article

References (62)

1. Couse J.F., and Korach K.S. Reproductive phenotypes in the estrogen receptor-alpha knockout mouse. Ann. Endocrinol. (Paris) 60 (1999) 143-148
2. Pettersson K., and Gustafsson J.A. Role of estrogen receptor beta in estrogen action. Annu. Rev. Physiol. 63 (2001) 165-192
3. Hall J.M., Couse J.F., and Korach K.S. The multifaceted mechanisms of estradiol and estrogen receptor signaling. J. Biol. Chem. 276 (2001) 36869-36872
4. Nilsson S., and Gustafsson J.A. Estrogen receptor action. Crit. Rev. Eukaryot. Gene Expr. 12 (2002) 237-257
5. Mangelsdorf D.J., Thummel C., Beato M., Herrlich P., SchÜtz G., Umesono K., Blumberg B., Kastner P., Mark M., Chambon P., and Evans R.M. The nuclear receptor superfamily: the second decade. Cell 83 (1995) 835-839
6. Green S., Walter P., Kumar V., Krust A., Bornert J.M., Argos P., and Chambon P. Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-A. Nature 320 (1986) 134-139
7. Green S., Walter P., Greene G., Krust A., Goffin C., Jensen E., Scrace G., Waterfield M., and Chambon P. Cloning of the human oestrogen receptor cDNA. J. Steroid Biochem. 24 (1986) 77-83
8. Kuiper G.G., Enmark E., Pelto-Huikko M., Nilsson S., and Gustafsson J.A. Cloning of a novel receptor expressed in rat prostate and ovary. Proc. Natl. Acad. Sci. USA 93 (1996) 5925-5930
9. Kelley S.T., and Thackray V.G. Phylogenetic analyses reveal ancient duplication of estrogen receptor isoforms. J. Mol. Evol. 49 (1999) 609-614
10. Lazennec G. Estrogen receptor beta, a possible tumor suppressor involved in ovarian carcinogenesis. Cancer Lett. 231 (2006) 151-157
11. Leung Y.K., Mak P., Hassan S., and Ho S.M. Estrogen receptor (ER)-beta isoforms: a key to understanding ER-beta signaling. Proc. Natl. Acad. Sci. USA 103 (2006) 13162-13167
12. Lewandowski S., Kalita K., and Kaczmarek L. Estrogen receptor beta, potential functional significance of a variety of mRNA isoforms. FEBS Lett. 524 (2002) 1-5
13. Tong D., Schuster E., Seifert M., Czerwenka K., Leodolte S., and Zeillinger R. Expression of estrogen receptor beta isoforms in human breast cancer tissues and cell lines. Breast Cancer Res. Treat. 71 (2002) 249-255
14. Ogawa S., Inoue S., Watanabe T., Hiroi H., Orimo A., Hosoi T., Ouchi Y., and Muramatsu M. The complete primary structure of human estrogen receptor beta (hER beta) and its heterodimerization with ER alpha in vivo and in vitro. Biochem. Biophys. Res. Commun. 243 (1998) 122-126
15. Matthews J., and Gustafsson J.A. Estrogen signaling: a subtle balance between ER alpha and ER beta. Mol. Interv. 3 (2003) 281-292
16. Roger P., Sahla M.E., Mäkalä S., Gustafsson J.A., Baldet P., and Rochefort H. Decreased expression of estrogen receptor beta protein in proliferative preinvasive mammary tumors. Cancer Res. 61 (2001) 2537-2541
17. Horvath L.G., Henshall S.M., Lee C.S., Head D.R., Quinn D.I., Makela S., Delprado W., Golovsky D., Brenner P.C., O'Neill G., Kooner R., Stricker P.D., Grygiel J.J., Gustafsson J.A., and Sutherland R.L. Frequent loss of estrogen receptor-beta expression in prostate cancer. Cancer Res. 61 (2001) 5331-5335
18. Stabile L.P., Davis A.L., Gubish C.T., Hopkins T.M., Luketich J.D., Christie N., Finkelstein S., and Siegfried J.M. Human non-small cell lung tumors and cells derived from normal lung express both estrogen receptor alpha and beta and show biological responses to estrogen. Cancer Res. 62 (2002) 2141-2150
19. Foley E.F., Jazaeri A.A., Shupnik M.A., Jazaeri O., and Rice L.W. Selective loss of estrogen receptor beta in malignant human colon. Cancer Res. 60 (2000) 245-248
20. Cheng G., Weihua Z., Warner M., and Gustafsson J.A. Estrogen receptor ER alpha and ER beta in proliferation in the rodent mammary gland. Proc. Natl. Acad. Sci. USA 101 (2004) 3739-3746
21. Chang E.C., Frasor J., Komm B., and Katzenellenbogen B.S. Impact of estrogen receptor beta on gene networks regulated by estrogen receptor alpha in breast cancer cells. Endocrinology 147 (2006) 4831-4842
22. Lin C.Y., Ström A., Li Kong S., Kietz S., Thomsen J.S., Tee J.B., Vega V.B., Miller L.D., Smeds J., Bergh J., Gustafsson J.A., and Liu E.T. Inhibitory effects of estrogen receptor beta on specific hormone-responsive gene expression and association with disease outcome in primary breast cancer. Breast Cancer Res. 9 (2007) R25
23. Gustafsson J.A., and Warner M. Estrogen receptor beta in the breast: role in estrogen responsiveness and development of breast cancer. J. Steroid Biochem. Mol. Biol. 74 (2000) 245-248
24. Zebedee Z., and Hara E. Id proteins in cell cycle control and cellular senescence. Oncogene 20 (2001) 8317-8325
25. Zhang X., Ling M.T., Wang Q., Lau C.K., Leung S.C., Lee T.K., Cheung A.L., Wong Y.C., and Wang X. Identification of a novel inhibitor of differentiation-1 (ID-1) binding partner, caveolin-1, and its role in epithelial-mesenchymal transition and resistance to apoptosis in prostate cancer cells. J. Biol. Chem. 282 (2007) 33284-33294
26. Norton J.D., Deed R.W., Craggs G., and Sablitzky F. Id helix-loop-helix proteins in cell growth and differentiation. Trends Cell Biol. 8 (1998) 58-65
27. Sikder H.A., Devlin M.K., Dunlap S., Ryu B., and Alani R.M. Id proteins in cell growth and tumorigenesis. Cancer Cell 3 (2003) 525-530
28. Ling M.T., Wang X., Ouyang X.S., Xu K., Tsao S.W., and Wong Y.C. Id-1 expression promotes cell survival through activation of NF-kappaB signaling pathway in prostate cancer cells. Oncogene 22 (2003) 4498-4508
29. Desprez P.Y., Lin C.Q., Thomasset N., Sympson C.J., Bissell M.J., and Campisi J. A novel pathway for mammary epithelial cell invasion induced by the helix-loop-helix protein Id-1. Mol. Cell. Biol. 18 (1998) 4577-4588
30. Kondo M., Cubillo E., Tobiume K., Shirakihara T., Fukuda N., Suzuki H., Shimizu K., Takehara K., Cano A., Saitoh M., and Miyazono K. A role for Id in the regulation of TGF-beta-induced epithelial-mesenchymal transdifferentiation. Cell Death Differ. 11 (2004) 1092-1101
31. Wiercinska E., Wickert L., Denecke B., Said H.M., Hamzavi J., Gressner A.M., Thorikay M., ten Dijke P., Mertens P.R., Breitkopf K., and Dooley S. Id1 is a critical mediator in TGF-beta-induced transdifferentiation of rat hepatic stellate cells. Hepatology 43 (2006) 1032-1041
32. Murphy L.C., Peng B., Lewis A., Davie J.R., Leygue E., Kemp A., Ung K., Vendetti M., and Shiu R. Inducible upregulation of oestrogen receptor-β1 affects oestrogen and tamoxifen responsiveness in MCF7 human breast cancer cells. J. Mol. Endocr. 34 (2005) 553-566
33. De Bessa S.A., Salaorni S., Patrão D.F., Neto M.M., Brentani M.M., and Nagai M.A. JDP1 (DNAJC12/Hsp40) expression in breast cancer and its association with estrogen receptor status. Int. J. Mol. Med. 17 (2006) 363-367
34. El-Deiry W.S., Tokino T., Velculescu V.E., Levy D.B., Parsons R., Trent J.M., Lin D., Mercer W.E., Kinzler K.W., and Vogelstein B. WAF1, a potential mediator of p53 tumor suppression. Cell 75 (1993) 817-825
35. Mak P., Leung Y.K., Tang W.Y., Harwood C., and Ho S.M. Apigenin suppresses cancer cell growth through ERbeta. Neoplasia 8 (2006) 896-904
36. Colditz G.A. Relationship between estrogen levels, use of hormone replacement therapy, and breast cancer. J. Natl. Cancer Inst. 90 (1998) 814-823
37. Clemons M., and Goss P. Estrogen and the risk of breast cancer. N. Engl. J. Med. 344 (2001) 276-285
38. Kuiper T.B., Langer W.D., and Velusamy T. Evolutionary status of the pre-protostellar core L1498. Astrophys. J. 468 (1996) 761-773
39. Leygue E., Dotzlaw H., Watson P.H., and Murphy L.C. Altered estrogen receptor alpha and beta messenger RNA expression during human breast tumorigenesis. Cancer Res. 58 (1998) 3197-3201
40. Skliris G.P., Munot K., Bell S.M., Carder P.J., Lane S., Horgan K., Lansdown M.R., Parkes A.T., Hanby A.M., Markham A.F., and Speirs V. Reduced expression of oestrogen receptor beta in invasive breast cancer and its re-expression using DNA methyl transferase inhibitors in a cell line model. J. Pathol. 201 (2003) 213-220
41. Murphy L.C., and Watson P.H. Is oestrogen receptor-beta a predictor of endocrine therapy responsiveness in human breast cancer?. Endocr. Relat. Cancer 13 (2006) 327-334
42. Fleming F.J., Hill A.D., McDermott E.W., O'Higgins N.J., and Young L.S. Differential recruitment of coregulator proteins steroid receptor coactivator-1 and silencing mediator for retinoid and thyroid receptors to the estrogen receptor-estrogen response element by beta-estradiol and 4-hydroxytamoxifen in human breast cancer. J. Clin. Endocrinol. Metab. 89 (2004) 375-383
43. Hopp T.A., Weiss H.L., Parra I.S., Cui Y., Osborne C.K., and Fuqua S.A. Low levels of estrogen receptor beta protein predict resistance to tamoxifen therapy in breast cancer. Clin. Cancer Res. 10 (2004) 7490-7499
44. Nakopoulou L., Lazaris A.C., Panayotopoulou E.G., Giannopoulou I., Givalos N., Markaki S., and Keramopoulos A. The favourable prognostic value of oestrogen receptor beta immunohistochemical expression in breast cancer. J. Clin. Pathol. 57 (2004) 523-528
45. Matsumura K., Tanaka T., Kawashima H., and Nakatani T. Involvement of the estrogen receptor beta in genistein-induced expression of p21(waf1/cip1) in PC-3 prostate cancer cells. Anticancer Res. 28 (2008) 709-714
46. Singh J., Itahana Y., Parrinello S., Murata K., and Desprez P.Y. Molecular cloning and characterization of a zinc finger protein involved in Id-1-stimulated mammary epithelial cell growth. J. Biol. Chem. 276 (2001) 11852-11858
47. Desprez P.Y., Sumida T., and Coppé J.P. Helix-loop-helix proteins in mammary gland development and breast cancer. J. Mammary Gland Biol. Neoplasia 8 (2003) 225-239
48. Wang Q., Tsao S.W., Fu S., Xue W., Meng X., Feng H., Wong Y.C., and Wang X. Overexpression of Id-1 in gastric adenocarcinoma: implication for a novel diagnostic marker. Anticancer Res. 24 (2004) 881-886
49. Yates P.R., Atherton G.T., Deed R.W., Norton J.D., and Sharrocks A.D. Id helix-loop-helix proteins inhibit nucleoprotein complex formation by the TCF ETS-domain transcription factors. EMBO J. 18 (1999) 968-976
50. Shoji W., Inoue T., Yamamoto T., and Obinata M. MIDA1, a protein associated with Id, regulates cell growth. J. Biol. Chem. 270 (1995) 24818-24825
51. Roberts E.C., Deed R.W., Inoue T., Norton J.D., and Sharrocks A.D. Id helix-loop-helix proteins antagonize pax transcription factor activity by inhibiting DNA binding. Mol. Cell. Biol. 21 (2001) 524-533
52. Sumida T., Itahana Y., Hamakawa H., and Desprez P.Y. Reduction of human metastatic breast cancer cell aggressiveness on introduction of either form a or B of the progesterone receptor and then treatment with progestins. Cancer Res. 64 (2004) 7886-7892
53. Schindl M., Oberhuber G., Obermair A., Schoppmann S.F., Karner B., and Birner P. Overexpression of Id-1 protein is a marker for unfavorable prognosis in early-stage cervical cancer. Cancer Res. 61 (2001) 5703-5706
54. Deed R.W., Bianchi S.M., Atherton G.T., Johnston D., Santibanez-Koref M., Murphy J.J., and Norton J.D. An immediate early human gene encodes an Id-like helix-loop-helix protein and is regulated by protein kinase C activation in diverse cell types. Oncogene 8 (1993) 599-607
55. Peverali F.A., Ramqvist T., Saffrich R., Pepperkok R., Barone M.V., and Philipson L. Regulation of G1 progression by E2A and Id helix-loop-helix proteins. EMBO J. 13 (1994) 4291-4301
56. Prabhu S., Ignatova A., Park S.T., and Sun X.H. Regulation of the expression of cyclin-dependent kinase inhibitor p21 by E2A and Id proteins. Mol. Cell. Biol. 17 (1997) 5888-5896
57. Kim H., Chung H., Kim H.J., Lee J.Y., Oh M.Y., Kim Y., and Kong G. Id1 regulates Bcl-2 and Bax expression through p53 and NF-kappaB in MCF-7 breast cancer cells. Breast Cancer Res. Treat. 112 (2008) 287-296
58. Asirvatham A.J., Carey J.P., and Chaudhary J. ID1-, ID2-, and ID3-regulated gene expression in E2A positive or negative prostate cancer cells. Prostate 67 (2007) 1411-1420
59. Ouyang X.S., Wang X., Ling M.T., Wong H.L., Tsao S.W., and Wong Y.C. Id-1 stimulates serum independent prostate cancer cell proliferation through inactivation of p16(INK4a)/pRB pathway. Carcinogenesis 23 (2002) 721-725
60. Hui C.M., Cheung P.Y., Ling M.T., Tsao S.W., Wang X., Wong Y.C., and Cheung A.L. Id-1 promotes proliferation of p53-deficient esophageal cancer cells. Int. J. Cancer 119 (2006) 508-514
61. Jang K.S., Han H.X., Paik S.S., Brown P.H., and Kong G. Id-1 overexpression in invasive ductal carcinoma cells is significantly associated with intratumoral microvessel density in ER-negative/node-positive breast cancer. Cancer Lett. 244 (2006) 203-210
62. Schoppmann S.F., Schindl M., Bayer G., Aumayr K., Dienes J., Horvat R., Rudas M., Gnant M., Jakesz R., and Birner P. Overexpression of Id-1 is associated with poor clinical outcome in node negative breast cancer. Int. J. Cancer 104 (2003) 677-682